DK0601345T3 - Lægemiddel Indeholdende en imidazol-l-yl-forbindelse - Google Patents

Lægemiddel Indeholdende en imidazol-l-yl-forbindelse

Info

Publication number
DK0601345T3
DK0601345T3 DK93118167.1T DK93118167T DK0601345T3 DK 0601345 T3 DK0601345 T3 DK 0601345T3 DK 93118167 T DK93118167 T DK 93118167T DK 0601345 T3 DK0601345 T3 DK 0601345T3
Authority
DK
Denmark
Prior art keywords
imidazol
compound
drug containing
anomalies
hydrogen
Prior art date
Application number
DK93118167.1T
Other languages
English (en)
Inventor
Christian Eeckhout
Ulf Preuschoff
Samuel David
Original Assignee
Kali Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh
Application granted granted Critical
Publication of DK0601345T3 publication Critical patent/DK0601345T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK93118167.1T 1992-11-14 1993-11-10 Lægemiddel Indeholdende en imidazol-l-yl-forbindelse DK0601345T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4238553A DE4238553A1 (de) 1992-11-14 1992-11-14 Neue Imidazol-1-yl-Verbindungen enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
DK0601345T3 true DK0601345T3 (da) 1996-11-18

Family

ID=6472938

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93118167.1T DK0601345T3 (da) 1992-11-14 1993-11-10 Lægemiddel Indeholdende en imidazol-l-yl-forbindelse

Country Status (24)

Country Link
US (1) US5438068A (da)
EP (1) EP0601345B1 (da)
JP (1) JP3683286B2 (da)
KR (1) KR100266715B1 (da)
CN (1) CN1041053C (da)
AT (1) ATE143597T1 (da)
AU (1) AU667243B2 (da)
CA (3) CA2538177A1 (da)
CZ (1) CZ284154B6 (da)
DE (2) DE4238553A1 (da)
DK (1) DK0601345T3 (da)
DZ (1) DZ1726A1 (da)
ES (1) ES2092206T3 (da)
GR (1) GR3021230T3 (da)
HK (1) HK1006537A1 (da)
HU (1) HU213506B (da)
IL (1) IL107454A (da)
MX (1) MX9307079A (da)
NO (1) NO303926B1 (da)
NZ (1) NZ250103A (da)
PH (1) PH30702A (da)
RU (1) RU2125877C1 (da)
SK (1) SK278874B6 (da)
ZA (1) ZA938463B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365743B1 (en) 1995-10-13 2002-04-02 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
AU702594B2 (en) * 1995-10-13 1999-02-25 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
DE19813661A1 (de) * 1997-08-01 1999-02-04 Solvay Pharm Gmbh Gegen Racemisierung stabilisierte pharmazeutische Zubereitungen von Cilansetron
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
US7015333B2 (en) * 2002-11-18 2006-03-21 Solvay Pharmaceuticals B.V. Process for preparation of imidazolyl compounds
EP1424337A1 (en) * 2002-11-26 2004-06-02 Solvay Pharmaceuticals GmbH 4-hydroxy derivatives of 5,6,9,10-tetrahydro-10-((2-methyl-1h-imidazol-1-yl)methyl)-4h-pyrido-(3,2,1-jk)-carbazol-11(8h)-one
KR20050111318A (ko) * 2003-01-13 2005-11-24 다이노젠 파마세우티컬스, 인코포레이티드 기능성 장 질환을 치료하는 방법
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0385517B1 (en) * 1985-03-14 1993-04-14 BEECHAM GROUP plc Medicaments for the treatment of emesis
DE3885357T2 (de) * 1987-06-29 1994-03-24 Duphar Int Res Anellierte Indolderivate.

Also Published As

Publication number Publication date
DZ1726A1 (fr) 2002-02-17
ATE143597T1 (de) 1996-10-15
AU5064393A (en) 1994-05-26
NO934090L (da) 1994-05-16
CZ236593A3 (en) 1994-05-18
US5438068A (en) 1995-08-01
KR940010999A (ko) 1994-06-20
NO303926B1 (no) 1998-09-28
ES2092206T3 (es) 1996-11-16
PH30702A (en) 1997-09-16
HUT65978A (en) 1994-08-29
CN1041053C (zh) 1998-12-09
JP3683286B2 (ja) 2005-08-17
NO934090D0 (no) 1993-11-12
CA2102960C (en) 2005-08-02
IL107454A0 (en) 1994-02-27
DE4238553A1 (de) 1994-05-19
CA2538177A1 (en) 1994-05-15
MX9307079A (es) 1994-05-31
ZA938463B (en) 1994-08-01
HK1006537A1 (en) 1999-03-05
JPH06211656A (ja) 1994-08-02
CA2504502A1 (en) 1994-05-15
CA2102960A1 (en) 1994-05-15
RU2125877C1 (ru) 1999-02-10
SK123593A3 (en) 1994-09-07
DE59304045D1 (de) 1996-11-07
CZ284154B6 (cs) 1998-08-12
NZ250103A (en) 1997-06-24
KR100266715B1 (ko) 2000-09-15
HU213506B (en) 1997-07-28
SK278874B6 (sk) 1998-04-08
IL107454A (en) 1999-12-22
EP0601345A1 (de) 1994-06-15
AU667243B2 (en) 1996-03-14
CN1092650A (zh) 1994-09-28
EP0601345B1 (de) 1996-10-02
GR3021230T3 (en) 1997-01-31

Similar Documents

Publication Publication Date Title
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
EA199800141A1 (ru) Гетероциклические соединения
DK0463560T3 (da) Nye antiepileptiske midler
NO975663L (no) Semikarbazoner med CNS aktivitet og farmasöytiske preparater inneholdende de samme
TW427982B (en) Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-one derivatives, process for their preparation and the pharmaceutical compositions containing them
DE59304045D1 (de) Imidazol-1-yl-Verbindung enthaltende Arzneimittel
DK296389A (da) Farmaceutiske forbindelser
DE69322250D1 (de) 3-hydroxypyridin-4-on-derivate als chelatbildner
UA42819C2 (uk) Ін`єкційний та інфузійний розчин, що містить енрофлокcацин
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
DE69227583D1 (de) Arylmorpholine, herstellung und verwendung
DE69103630D1 (de) Oxazolederivate, ihre herstellung und diese enthaltende pharmazeutischen zubereitungen.
ES2104509A1 (es) Nuevos compuestos derivados de 2-(3,4-disustituido-1-piperazinil)-5-fluoropirimidina.
GR3005101T3 (da)
ES2104938T3 (es) Metodo de inhibir la fibrosis.
MX9205385A (es) Perhidro-1-h-pirido(1,2-a)piracinas 2-sustituidas neurolepticas.
ATE66221T1 (de) Substituierte 5-amino-pyrazole und diese enthaltende fungizide.
AU553493B2 (en) 3,7alpha-diazacyclohepta(j,k)fluoriene derivatives
DE3862660D1 (de) 2,3-dihydro-2-oxo-3-benzofuranyl-essigsaeurederivate und diese enthaltende arzneimittel.
TR199701604T2 (xx) Pirol t�revleri i�in yeni ba�vuru
ATE9892T1 (de) Dibenzocycloheptenylidene und ihre verwendung in pharmazeutischen zusammensetzungen.
NO164170C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzhydryl-4-cinnamyl-piperazinderivater.
ES2103232A1 (es) Nuevos compuestos derivados de 1h-imidazol-2-metanol.
TH22766A (th) อนุพันธ์ของแอมีดและยูเรียที่มีฤทธิ์ป้องกันหรือบรร?เทาอาการโรคโลหิตมีคอเลสเทอรอลมากเกินไป,การเตรียม?สารเหล่านั้นและการใช้สารเหล่านั้นเป็นยารักษาโรค